Invesco Ltd

As of June 30, 2026, Invesco Ltd. carries a market capitalization of 11.61B, placing it among publicly traded companies globally. Its enterprise value stands at 22.77B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Invesco Ltd.'s next confirmed earnings release is scheduled for October 27, 2026.

As of June 30, 2026, Invesco Ltd. has 441.50M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 1.72, and the price-to-book ratio stands at 1.17.

These figures are as of June 30, 2026. The EV/Sales ratio of 3.30 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 22.77B versus a market cap of 11.61B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Invesco Ltd. maintains a current ratio of 6.82, meaning it holds 6.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 68.79, indicating elevated leverage, while an interest coverage ratio of -3.62 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Invesco Ltd. posted a negative return on equity (ROE) of -2.19, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -0.23, reflecting losses generated across the asset base. The company generates approximately 890,501.53 in revenue per employee across its workforce of 7,751.25, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Invesco Ltd. recorded an income tax benefit of -161.60M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -243.10M and -64.50M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Invesco Ltd.'s stock has gained approximately 26.20% over the past 52 weeks. The 50-day moving average sits at 30.98, while the 200-day moving average is 27.98.

Over the twelve months ended June 30, 2026, Invesco Ltd. generated 6.90B in revenue and converted that into -64.50M in net income, yielding earnings per share of -0.18. EBITDA reached -350.10M, while operating income came in at -489.80M.

As of June 30, 2026, Invesco Ltd. holds 1.61B in cash and equivalents against 9.27B in total debt, resulting in a net debt position of 7.66B. Total book value stands at 9.96B, with working capital of 9.41B providing operational flexibility.

Invesco Ltd. produced 2.01B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -88.10M in capital expenditures, free cash flow totaled 1.92B - equivalent to 4.25 per share.

Over the twelve months ended June 30, 2026, Invesco Ltd. posted a gross margin of 35.78, reflecting its pricing power and cost economics. The operating margin of -7.10 and net profit margin of -0.93 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Invesco Ltd. paid dividends of 1.21 per share. The dividend payout ratio of -145.41 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 16.09, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -1.69, meaning Invesco Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Invesco Ltd.'s most recent stock split took place on November 8, 2000 with a 2:5 split ratio.

As of June 30, 2026, Invesco Ltd. has an Altman Z-Score of 2.17, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.